Skip to main content
Oncolys BioPharma Inc. logo

Oncolys BioPharma Inc. — Investor Relations & Filings

Ticker · 4588 ISIN · JP3202170001 T Manufacturing
Open in API
Filings indexed 83 across all filing types
Latest filing 2023-03-30 Governance Information
Country JP Japan
Listing T 4588

About Oncolys BioPharma Inc.

https://www.oncolys.com/en/

Oncolys BioPharma Inc. is a biopharmaceutical company focused on the research and development of breakthrough therapies and diagnostics for cancer. The company's core technology is oncolytic virotherapy, which utilizes viruses to selectively target and destroy cancer cells. Its development pipeline addresses multiple stages of cancer care, spanning from early detection and prognostic testing to loco-regional and systemic treatments. The company aims to develop innovative and effective drugs to meet the needs of patients and healthcare providers in the field of oncology.

Recent filings

Filing Released Lang Actions
内部統制報告書－第19期(2022/01/01－2022/12/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. Since it is a standalone regulatory report concerning audit-related internal control standards rather than a full annual report, a management discussion, or a simple announcement, it falls under the 'Audit Report / Information' category.
2023-03-30 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a mandatory internal control and accuracy certification filed alongside the Annual Securities Report (Yukashoken Hokokusho) in Japan. Since it is a standalone regulatory filing confirming the accuracy of the annual report rather than the annual report itself, and it does not fit into other specific categories like '10-K' or 'AR', it is classified as a general regulatory filing. FY 2022
2023-03-30 Japanese
有価証券報告書－第19期(2022/01/01－2022/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, business history, and management information for the fiscal year ending December 31, 2022. The document structure, including the cover page and the 'Corporate Information' section, confirms it is the official annual filing. FY 2022
2023-03-30 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO and CFO regarding the accuracy of a previously filed Securities Report (Yuuka Shouken Houkokusho). Since it is a regulatory filing confirming the validity of financial disclosures and does not fit into specific categories like 10-K or IR, it falls under the general regulatory filing category. FY 2021
2022-11-17 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO and CFO regarding the accuracy of a previously filed Annual Securities Report (Yuuka Shouken Houkokusho). Since this is a regulatory filing confirming the validity of financial disclosures and does not fit into specific categories like earnings releases or annual reports themselves, it is classified as a general regulatory filing. FY 2020
2022-11-17 Japanese
訂正有価証券報告書－第18期(令和3年1月1日－令和3年12月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, business history, and management information for the fiscal year ending December 31, 2021. The document structure, including the 'Corporate Information' section and the 'Major Management Indicators' table, confirms it is a comprehensive annual financial report. FY 2021
2022-11-17 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.